Spliceosomal component Sf3b1 is essential for hematopoietic differentiation in zebrafish

Adriana De La Garza, Rosannah C. Cameron, Sara Nik, Sara G. Payne, Teresa V. Bowman

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

SF3B1 (Splicing factor 3b, subunit 1) is one of the most commonly mutated factors in myelodysplastic syndrome (MDS). Although the genetic correlation between SF3B1 mutations and MDS etiology are quite strong, no in vivo model currently exists to explore how SF3B1 loss alters blood cell development. Using zebrafish mutants, we show here that proper function of Sf3b1 is required for all hematopoietic lineages. As in MDS patients, zebrafish sf3b1 mutants develop a macrocytic-anemia–like phenotype due to a block in maturation at a late progenitor stage. The mutant embryos also develop neutropenia, because their primitive myeloid cells fail to mature and turn on differentiation markers such as l-plastin and myeloperoxidase. In contrast, production of definitive hematopoietic stem and progenitor cells (HSPCs) from hemogenic endothelial cells within the dorsal aorta is greatly diminished, whereas arterial endothelial cells are correctly fated. Notch signaling, imperative for the endothelial-to-hematopoietic transition, is also normal, indicating that HSPC induction is blocked in sf3b1 mutants downstream or independent of Notch signaling. The data demonstrate that Sf3b1 function is necessary during key differentiation fate decisions in multiple blood cell types. Zebrafish sf3b1 mutants offer a novel animal model with which to explore the role of splicing in hematopoietic development and provide an excellent in vivo system with which to delve into the question of why and how Sf3b1 dysfunction is detrimental to hematopoietic differentiation, which could improve MDS diagnosis and treatment.

Original languageEnglish (US)
Pages (from-to)826-837.e4
JournalExperimental Hematology
Volume44
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Myelodysplastic Syndromes
Zebrafish
Hematopoietic Stem Cells
Blood Cells
Hemangioblasts
Differentiation Antigens
Myeloid Cells
Neutropenia
Peroxidase
Aorta
Embryonic Structures
Endothelial Cells
Animal Models
Phenotype
Mutation
RNA Splicing Factors
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Molecular Biology
  • Genetics
  • Cell Biology
  • Cancer Research

Cite this

Spliceosomal component Sf3b1 is essential for hematopoietic differentiation in zebrafish. / De La Garza, Adriana; Cameron, Rosannah C.; Nik, Sara; Payne, Sara G.; Bowman, Teresa V.

In: Experimental Hematology, Vol. 44, No. 9, 01.09.2016, p. 826-837.e4.

Research output: Contribution to journalArticle

De La Garza, Adriana ; Cameron, Rosannah C. ; Nik, Sara ; Payne, Sara G. ; Bowman, Teresa V. / Spliceosomal component Sf3b1 is essential for hematopoietic differentiation in zebrafish. In: Experimental Hematology. 2016 ; Vol. 44, No. 9. pp. 826-837.e4.
@article{fabf0ee687604882b297ebd2f7799989,
title = "Spliceosomal component Sf3b1 is essential for hematopoietic differentiation in zebrafish",
abstract = "SF3B1 (Splicing factor 3b, subunit 1) is one of the most commonly mutated factors in myelodysplastic syndrome (MDS). Although the genetic correlation between SF3B1 mutations and MDS etiology are quite strong, no in vivo model currently exists to explore how SF3B1 loss alters blood cell development. Using zebrafish mutants, we show here that proper function of Sf3b1 is required for all hematopoietic lineages. As in MDS patients, zebrafish sf3b1 mutants develop a macrocytic-anemia–like phenotype due to a block in maturation at a late progenitor stage. The mutant embryos also develop neutropenia, because their primitive myeloid cells fail to mature and turn on differentiation markers such as l-plastin and myeloperoxidase. In contrast, production of definitive hematopoietic stem and progenitor cells (HSPCs) from hemogenic endothelial cells within the dorsal aorta is greatly diminished, whereas arterial endothelial cells are correctly fated. Notch signaling, imperative for the endothelial-to-hematopoietic transition, is also normal, indicating that HSPC induction is blocked in sf3b1 mutants downstream or independent of Notch signaling. The data demonstrate that Sf3b1 function is necessary during key differentiation fate decisions in multiple blood cell types. Zebrafish sf3b1 mutants offer a novel animal model with which to explore the role of splicing in hematopoietic development and provide an excellent in vivo system with which to delve into the question of why and how Sf3b1 dysfunction is detrimental to hematopoietic differentiation, which could improve MDS diagnosis and treatment.",
author = "{De La Garza}, Adriana and Cameron, {Rosannah C.} and Sara Nik and Payne, {Sara G.} and Bowman, {Teresa V.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.exphem.2016.05.012",
language = "English (US)",
volume = "44",
pages = "826--837.e4",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Spliceosomal component Sf3b1 is essential for hematopoietic differentiation in zebrafish

AU - De La Garza, Adriana

AU - Cameron, Rosannah C.

AU - Nik, Sara

AU - Payne, Sara G.

AU - Bowman, Teresa V.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - SF3B1 (Splicing factor 3b, subunit 1) is one of the most commonly mutated factors in myelodysplastic syndrome (MDS). Although the genetic correlation between SF3B1 mutations and MDS etiology are quite strong, no in vivo model currently exists to explore how SF3B1 loss alters blood cell development. Using zebrafish mutants, we show here that proper function of Sf3b1 is required for all hematopoietic lineages. As in MDS patients, zebrafish sf3b1 mutants develop a macrocytic-anemia–like phenotype due to a block in maturation at a late progenitor stage. The mutant embryos also develop neutropenia, because their primitive myeloid cells fail to mature and turn on differentiation markers such as l-plastin and myeloperoxidase. In contrast, production of definitive hematopoietic stem and progenitor cells (HSPCs) from hemogenic endothelial cells within the dorsal aorta is greatly diminished, whereas arterial endothelial cells are correctly fated. Notch signaling, imperative for the endothelial-to-hematopoietic transition, is also normal, indicating that HSPC induction is blocked in sf3b1 mutants downstream or independent of Notch signaling. The data demonstrate that Sf3b1 function is necessary during key differentiation fate decisions in multiple blood cell types. Zebrafish sf3b1 mutants offer a novel animal model with which to explore the role of splicing in hematopoietic development and provide an excellent in vivo system with which to delve into the question of why and how Sf3b1 dysfunction is detrimental to hematopoietic differentiation, which could improve MDS diagnosis and treatment.

AB - SF3B1 (Splicing factor 3b, subunit 1) is one of the most commonly mutated factors in myelodysplastic syndrome (MDS). Although the genetic correlation between SF3B1 mutations and MDS etiology are quite strong, no in vivo model currently exists to explore how SF3B1 loss alters blood cell development. Using zebrafish mutants, we show here that proper function of Sf3b1 is required for all hematopoietic lineages. As in MDS patients, zebrafish sf3b1 mutants develop a macrocytic-anemia–like phenotype due to a block in maturation at a late progenitor stage. The mutant embryos also develop neutropenia, because their primitive myeloid cells fail to mature and turn on differentiation markers such as l-plastin and myeloperoxidase. In contrast, production of definitive hematopoietic stem and progenitor cells (HSPCs) from hemogenic endothelial cells within the dorsal aorta is greatly diminished, whereas arterial endothelial cells are correctly fated. Notch signaling, imperative for the endothelial-to-hematopoietic transition, is also normal, indicating that HSPC induction is blocked in sf3b1 mutants downstream or independent of Notch signaling. The data demonstrate that Sf3b1 function is necessary during key differentiation fate decisions in multiple blood cell types. Zebrafish sf3b1 mutants offer a novel animal model with which to explore the role of splicing in hematopoietic development and provide an excellent in vivo system with which to delve into the question of why and how Sf3b1 dysfunction is detrimental to hematopoietic differentiation, which could improve MDS diagnosis and treatment.

UR - http://www.scopus.com/inward/record.url?scp=84989898012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989898012&partnerID=8YFLogxK

U2 - 10.1016/j.exphem.2016.05.012

DO - 10.1016/j.exphem.2016.05.012

M3 - Article

C2 - 27260753

AN - SCOPUS:84989898012

VL - 44

SP - 826-837.e4

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 9

ER -